Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation

Romana Tomasoni, Veronica Basso, Karolina Pilipow, Giovanni Sitia, Simona Saccani, Alessandra Agresti, Flore Mietton, Gioacchino Natoli, Sara Colombetti, Anna Mondino

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The mammalian target of rapamycin (mTOR) controls T-cell differentiation in response to polarizing cytokines. We previously found that mTOR blockade by rapamycin (RAPA) delays the G1-S cell cycle transition and lymphocyte proliferation. Here, we report that both mTOR complex 1 and mTOR complex 2 are readily activated following TCR/CD28 engagement and are critical for early expression of Ifng, Il4 and Foxp3, and for effector T cell differentiation in the absence of polarizing cytokines. While inhibition of mTOR complex 1 and cell division were evident at low doses of RAPA, inhibition of mTOR complex 2, Ifng, Il4 and Foxp3 expression, and T-cell polarization required higher doses and more prolonged treatments. We found that while T-bet and GATA3 were readily induced following TCR/CD28 engagement, administration of RAPA delayed their expression, and interfered with the loss of DNA methylation within Ifng and Il4 promoter regions. In contrast, RAPA prevented activation-dependent DNA methylation of the Foxp3 promoter favoring Foxp3 expression. As a result, RAPA-cultured cells lacked immediate effector functions and instead were enriched for IL-2 + cells. We propose that mTOR-signaling, by timing the expression of critical transcription factors and DNA methylation of proximal promoter regions, regulates transcriptional competence at immunologically relevant sites and hence lymphocyte differentiation.

Original languageEnglish
Pages (from-to)2086-2096
Number of pages11
JournalEuropean Journal of Immunology
Volume41
Issue number7
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Sirolimus
Genetic Promoter Regions
Methylation
DNA Methylation
T-Lymphocytes
Cell Differentiation
Lymphocytes
Cytokines
Cell Division
Mental Competency
Interleukin-2
Cultured Cells
Cell Cycle
Transcription Factors

Keywords

  • Cell differentiation
  • Cellular activation
  • Gene expression
  • T helper cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation. / Tomasoni, Romana; Basso, Veronica; Pilipow, Karolina; Sitia, Giovanni; Saccani, Simona; Agresti, Alessandra; Mietton, Flore; Natoli, Gioacchino; Colombetti, Sara; Mondino, Anna.

In: European Journal of Immunology, Vol. 41, No. 7, 07.2011, p. 2086-2096.

Research output: Contribution to journalArticle

@article{62949438b24f4ea0afe5a7cdc44017cc,
title = "Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation",
abstract = "The mammalian target of rapamycin (mTOR) controls T-cell differentiation in response to polarizing cytokines. We previously found that mTOR blockade by rapamycin (RAPA) delays the G1-S cell cycle transition and lymphocyte proliferation. Here, we report that both mTOR complex 1 and mTOR complex 2 are readily activated following TCR/CD28 engagement and are critical for early expression of Ifng, Il4 and Foxp3, and for effector T cell differentiation in the absence of polarizing cytokines. While inhibition of mTOR complex 1 and cell division were evident at low doses of RAPA, inhibition of mTOR complex 2, Ifng, Il4 and Foxp3 expression, and T-cell polarization required higher doses and more prolonged treatments. We found that while T-bet and GATA3 were readily induced following TCR/CD28 engagement, administration of RAPA delayed their expression, and interfered with the loss of DNA methylation within Ifng and Il4 promoter regions. In contrast, RAPA prevented activation-dependent DNA methylation of the Foxp3 promoter favoring Foxp3 expression. As a result, RAPA-cultured cells lacked immediate effector functions and instead were enriched for IL-2 + cells. We propose that mTOR-signaling, by timing the expression of critical transcription factors and DNA methylation of proximal promoter regions, regulates transcriptional competence at immunologically relevant sites and hence lymphocyte differentiation.",
keywords = "Cell differentiation, Cellular activation, Gene expression, T helper cells",
author = "Romana Tomasoni and Veronica Basso and Karolina Pilipow and Giovanni Sitia and Simona Saccani and Alessandra Agresti and Flore Mietton and Gioacchino Natoli and Sara Colombetti and Anna Mondino",
year = "2011",
month = "7",
doi = "10.1002/eji.201041130",
language = "English",
volume = "41",
pages = "2086--2096",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "wiley",
number = "7",

}

TY - JOUR

T1 - Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation

AU - Tomasoni, Romana

AU - Basso, Veronica

AU - Pilipow, Karolina

AU - Sitia, Giovanni

AU - Saccani, Simona

AU - Agresti, Alessandra

AU - Mietton, Flore

AU - Natoli, Gioacchino

AU - Colombetti, Sara

AU - Mondino, Anna

PY - 2011/7

Y1 - 2011/7

N2 - The mammalian target of rapamycin (mTOR) controls T-cell differentiation in response to polarizing cytokines. We previously found that mTOR blockade by rapamycin (RAPA) delays the G1-S cell cycle transition and lymphocyte proliferation. Here, we report that both mTOR complex 1 and mTOR complex 2 are readily activated following TCR/CD28 engagement and are critical for early expression of Ifng, Il4 and Foxp3, and for effector T cell differentiation in the absence of polarizing cytokines. While inhibition of mTOR complex 1 and cell division were evident at low doses of RAPA, inhibition of mTOR complex 2, Ifng, Il4 and Foxp3 expression, and T-cell polarization required higher doses and more prolonged treatments. We found that while T-bet and GATA3 were readily induced following TCR/CD28 engagement, administration of RAPA delayed their expression, and interfered with the loss of DNA methylation within Ifng and Il4 promoter regions. In contrast, RAPA prevented activation-dependent DNA methylation of the Foxp3 promoter favoring Foxp3 expression. As a result, RAPA-cultured cells lacked immediate effector functions and instead were enriched for IL-2 + cells. We propose that mTOR-signaling, by timing the expression of critical transcription factors and DNA methylation of proximal promoter regions, regulates transcriptional competence at immunologically relevant sites and hence lymphocyte differentiation.

AB - The mammalian target of rapamycin (mTOR) controls T-cell differentiation in response to polarizing cytokines. We previously found that mTOR blockade by rapamycin (RAPA) delays the G1-S cell cycle transition and lymphocyte proliferation. Here, we report that both mTOR complex 1 and mTOR complex 2 are readily activated following TCR/CD28 engagement and are critical for early expression of Ifng, Il4 and Foxp3, and for effector T cell differentiation in the absence of polarizing cytokines. While inhibition of mTOR complex 1 and cell division were evident at low doses of RAPA, inhibition of mTOR complex 2, Ifng, Il4 and Foxp3 expression, and T-cell polarization required higher doses and more prolonged treatments. We found that while T-bet and GATA3 were readily induced following TCR/CD28 engagement, administration of RAPA delayed their expression, and interfered with the loss of DNA methylation within Ifng and Il4 promoter regions. In contrast, RAPA prevented activation-dependent DNA methylation of the Foxp3 promoter favoring Foxp3 expression. As a result, RAPA-cultured cells lacked immediate effector functions and instead were enriched for IL-2 + cells. We propose that mTOR-signaling, by timing the expression of critical transcription factors and DNA methylation of proximal promoter regions, regulates transcriptional competence at immunologically relevant sites and hence lymphocyte differentiation.

KW - Cell differentiation

KW - Cellular activation

KW - Gene expression

KW - T helper cells

UR - http://www.scopus.com/inward/record.url?scp=79959770321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959770321&partnerID=8YFLogxK

U2 - 10.1002/eji.201041130

DO - 10.1002/eji.201041130

M3 - Article

C2 - 21480212

AN - SCOPUS:79959770321

VL - 41

SP - 2086

EP - 2096

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 7

ER -